New morpholino anthracyclines, MX, MX2, and MY5.
D000818:Animals; D018943:Anthracyclines; D000900:Anti-Bacterial Agents / Q000032:analysis / Q000138:chemical synthesis*; D000903:Antibiotics, Antineoplastic; D002360:Carubicin / Q000031:analogs & derivatives*; D007941:Leukemia P388 / Q000188:drug therapy; D051379:Mice; D009279:Naphthacenes / Q000032:analysis / Q000138:chemical synthesis
D018943:Anthracyclines; D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D009279:Naphthacenes; C053536:morpholinoanthracycline MX; C053537:morpholinoanthracycline MX2; C053538:morpholinoanthracycline MY5; D002360:Carubicin